Figure 2: A 32/female with HL, post 3 cycles ABVD, iPET showed significant disease regression. The same treatment regimen was continued and the patient did well as seen in the EOT scan, EOT: End of treatment, HL: Hodgkin's lymphoma, ABVD: Adriamycin, Bleomycin, Vinblastin and Dacarbazine